Safety Recommendations and Medical Liability in Ocular Surgery during the COVID-19 Pandemic: An Unsolved Dilemma.

COVID-19 SARS-CoV-2 coronavirus eye eye surgery guidelines medical liability ocular surgery recommendations

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
09 May 2020
Historique:
received: 01 05 2020
accepted: 06 05 2020
entrez: 14 5 2020
pubmed: 14 5 2020
medline: 14 5 2020
Statut: epublish

Résumé

Ocular surgery is one of the most performed medical procedures in the world. Its limitation or suspension, recursively extended over time, could be associated with a significant increase in the number of blind people worldwide. Indeed, cataract causes more than half of all cases of visual impairment in those countries with limited availability of means for performing eye operations (e.g., Africa or India). In this scenario, the pandemic of coronavirus disease 2019 (COVID-19) quickly resulted in the suspension or sharp reduction of various ophthalmic activities considered non-urgent, including lens replacement surgery or some intraocular injections. Despite the imperative need to continuously practice eye operations to avoid the abovementioned problems, there are currently little-shared and vague recommendations among the various countries on safety in operating rooms (for health care workers and patients) and poor legal protection for surgeons (potentially transmitting the COVID-19 infectious agent). Herein, we individuated and discussed some critical points in safety recommendations and medical liability. A paradigm shift for ocular surgery during the COVID-19 era is now mandatory. While telemedicine has been able to solve some problems in clinical ophthalmology, the lack of adequate health and legal protection for surgeons and patients may result in an excessive reduction in the volume of surgical interventions during a pandemic era and the immediately following period, thus determining inability to ensure health care to all patients.

Identifiants

pubmed: 32397530
pii: jcm9051403
doi: 10.3390/jcm9051403
pmc: PMC7290727
pii:
doi:

Types de publication

Editorial

Langues

eng

Références

J Clin Med. 2020 Apr 16;9(4):
pubmed: 32316118
Retina. 2016 Jan;36(1):137-47
pubmed: 26200516
J Clin Med. 2020 Mar 02;9(3):
pubmed: 32131486
Eye Vis (Lond). 2020 Apr 7;7:19
pubmed: 32289038
JAMA. 2020 Apr 1;:
pubmed: 32236491
JAMA. 2020 Mar 12;:
pubmed: 32163102
J Clin Med. 2020 Apr 28;9(5):
pubmed: 32353982
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
JAMA. 2020 Apr 27;:
pubmed: 32338711

Auteurs

Pietro Emanuele Napoli (PE)

Department of Surgical Science, University of Cagliari, Eye Clinic, via Ospedale 46, 09124 Cagliari, Italy.

Matteo Nioi (M)

Department of Clinical Sciences and Public Health, University of Cagliari, Forensic Medicine Unit, 09124 Cagliari, Italy.

Ernesto d'Aloja (E)

Department of Clinical Sciences and Public Health, University of Cagliari, Forensic Medicine Unit, 09124 Cagliari, Italy.

Maurizio Fossarello (M)

Department of Surgical Science, University of Cagliari, Eye Clinic, via Ospedale 46, 09124 Cagliari, Italy.
Clinica Oculistica, San Giovanni di Dio Hospital, Azienda Ospedaliera Universitaria di Cagliari, 09124 Cagliari, Italy.

Classifications MeSH